Reuters logo
BRIEF-Vascular Biogenics' VB-111 demonstrated significant increase in overall survival
2016年6月6日 / 上午11点12分 / 1 年前

BRIEF-Vascular Biogenics' VB-111 demonstrated significant increase in overall survival

June 6 (Reuters) - Vascular Biogenics Ltd :

* VB-111 demonstrated a statistically significant increase in overall survival at therapeutic versus low dose level

* Clinical data supported by immunotherapeutic effect observed in biopsies following treatment with VB-111 Source text for Eikon: Further company coverage: (Bengaluru Newsroom: +1-646-223-8780)

我们的标准:汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below